Investor Relations


Corporate Profile
Founded in 2011, Fulgent began with two simple ideas; flexibility and affordability. Today, we strive to create the most effective and wide ranging tests on the market. All of this is done in the pursuit of bettering the everyday lives of our customers. We shine brightest when meaningful relationships, passion, and purpose come together.

NASDAQ | FLGT (Common Stock)



 0.2 (5.56%)


11/12/18  4:00 p.m. ET

Data provided by Nasdaq. Minimum 15 minutes delayed.

Stock Quote

Stock chart for: FLGT.O.  Currently trading at $3.40 with a 52 week high of $5.56 and a 52 week low of $2.90.

Press Releasesview all press releases»
Fulgent Genetics Reports Third Quarter 2018 Financial Results

Read More

Fulgent Genetics to Announce Third Quarter 2018 Financial Results on Tuesday November 6, 2018

Read More

StemCyte and Fulgent Genetics Partner to Provide Comprehensive Genetic Analysis for Families

Read More

Upcoming Eventsview all events»
There are currently no events scheduled.